Biopharmaceutical preparations for the treatment of cancers; antibodies and antibody derivatives and fragments, namely, human monoclonal antibodies and their derivatives and fragments for medical use; biopharmaceutical preparations for the treatment of cancer of the skin, of the brain, and of soft tissue